Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival.

Hjelle KM, Johannesen TB, Bostad L, Reisæter LAR, Beisland C.

Eur Urol Oncol. 2018 Aug;1(3):252-261. doi: 10.1016/j.euo.2018.04.001. Epub 2018 May 15.

2.

Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study.

Bjørneklett R, Solbakken V, Bostad L, Fismen AS.

Patholog Res Int. 2018 Jun 3;2018:5653612. doi: 10.1155/2018/5653612. eCollection 2018.

3.

Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study.

Bjørneklett R, Bostad L, Fismen AS.

Biomed Res Int. 2018 May 31;2018:7581567. doi: 10.1155/2018/7581567. eCollection 2018.

4.
5.

Exploring sex-specific differences in the presentation and outcomes of ANCA-associated vasculitis: a nationwide registry-based cohort study.

Bjørneklett R, Solbakken V, Bostad L, Fismen AS.

Int Urol Nephrol. 2018 Jul;50(7):1311-1318. doi: 10.1007/s11255-018-1888-8. Epub 2018 May 22.

PMID:
29790004
6.

Tumour cell expression of interleukin 6 receptor α is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma.

Pilskog M, Bostad L, Edelmann RJ, Akslen LA, Beisland C, Straume O.

J Pathol Clin Res. 2018 Apr;4(2):114-123. doi: 10.1002/cjp2.96. Epub 2018 Mar 5.

7.

Cancer in ANCA-Associated Glomerulonephritis: A Registry-Based Cohort Study.

Sriskandarajah S, Bostad L, Myklebust TÅ, Møller B, Skrede S, Bjørneklett R.

Int J Nephrol. 2017;2017:6013038. doi: 10.1155/2017/6013038. Epub 2017 Dec 18.

8.

Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma.

Pilskog M, Beisland C, Akslen LA, Bostad L, Haug Å, Heinrich D, Hjelle KM, Straume O.

BMC Urol. 2017 Aug 31;17(1):74. doi: 10.1186/s12894-017-0267-6.

9.

Prognostic Value of Histologic Classification of ANCA-Associated Glomerulonephritis.

Bjørneklett R, Sriskandarajah S, Bostad L.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2159-2167. Epub 2016 Oct 18.

10.

Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study.

Voltersvik P, Aqrawi LA, Dudman S, Hungnes O; Norwegian Lung Pathology Group, Bostad L, Brokstad KA, Cox RJ.

Influenza Other Respir Viruses. 2016 Nov;10(6):525-531. doi: 10.1111/irv.12410. Epub 2016 Sep 1.

11.

A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use.

Beisland C, Guðbrandsdottir G, Reisæter LA, Bostad L, Hjelle KM.

World J Urol. 2016 Aug;34(8):1087-99. doi: 10.1007/s00345-016-1796-4. Epub 2016 Feb 27.

PMID:
26922650
13.

Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.

Guðbrandsdottir G, Hjelle KM, Frugård J, Bostad L, Aarstad HJ, Beisland C.

Scand J Urol. 2015;49(5):388-94. doi: 10.3109/21681805.2015.1021833.

PMID:
25773545
14.

Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma.

Beisland C, Gudbrandsdottir G, Reisæter LA, Bostad L, Wentzel-Larsen T, Hjelle KM.

Scand J Urol. 2015 Jun;49(3):205-10. doi: 10.3109/21681805.2014.980844. Epub 2014 Nov 25.

PMID:
25423093
15.

Health-related quality of life in long-term survivors after renal cancer treatment.

Beisland C, Beisland E, Hjelle KM, Bostad L, Hjermstad MJ, Aarstad AK, Aarstad HJ.

Scand J Urol. 2014 Feb;48(1):52-64. doi: 10.3109/21681805.2013.813963. Epub 2013 Jul 24.

PMID:
23883326
16.

Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma.

Sand KE, Hjelle KM, Rogde ÅJ, Gudbrandsđottir G, Bostad L, Beisland C.

Scand J Urol. 2013 Dec;47(6):462-71. doi: 10.3109/21681805.2013.777364. Epub 2013 Mar 21.

PMID:
23517346
17.

Diagnostic yield of biopsies of cervical lymph nodes using a large (14-gauge) core biopsy needle.

Pedersen OM, Aarstad HJ, Løkeland T, Bostad L.

APMIS. 2013 Dec;121(12):1119-30. doi: 10.1111/apm.12058. Epub 2013 Mar 13.

PMID:
23489251
18.

Agalsidase benefits renal histology in young patients with Fabry disease.

Tøndel C, Bostad L, Larsen KK, Hirth A, Vikse BE, Houge G, Svarstad E.

J Am Soc Nephrol. 2013 Jan;24(1):137-48. doi: 10.1681/ASN.2012030316.

19.

Expression of apoptosis associated proteins Survivin, Livin and Thrombospondin-1 in Burkitt lymphoma.

Kalungi S, Wabinga H, Bostad L.

APMIS. 2013 Mar;121(3):239-45. doi: 10.1111/j.1600-0463.2012.02962.x. Epub 2012 Aug 8.

PMID:
23030305
20.

[A man in his fifties with fever, cough and anuria].

Rui PO, Svarstad E, Bostad L, Vikse BE.

Tidsskr Nor Laegeforen. 2012 Aug 7;132(14):1621-4. doi: 10.4045/tidsskr.11.0356. Norwegian. No abstract available.

21.

Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010.

Tøndel C, Vikse BE, Bostad L, Svarstad E.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1591-7. doi: 10.2215/CJN.02150212. Epub 2012 Jul 26.

22.

Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.

Rogde AJ, Gudbrandsdottir G, Hjelle KM, Sand KE, Bostad L, Beisland C.

Scand J Urol Nephrol. 2012 Oct;46(5):348-57. doi: 10.3109/00365599.2012.678382. Epub 2012 Apr 25.

PMID:
22530756
23.

Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort.

Bjørneklett R, Vikse BE, Bostad L, Leivestad T, Iversen BM.

Nephrol Dial Transplant. 2012 Apr;27(4):1485-91. doi: 10.1093/ndt/gfr446. Epub 2011 Aug 5.

PMID:
21821835
24.

Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients.

Bjørneklett R, Vikse BE, Smerud HK, Bostad L, Leivestad T, Hartmann A, Iversen BM.

Clin Transplant. 2011 May-Jun;25(3):E356-65. doi: 10.1111/j.1399-0012.2011.01424.x. Epub 2011 Mar 9.

PMID:
21651619
25.

Fabry or not Fabry--a question of ascertainment.

Houge G, Tøndel C, Kaarbøe O, Hirth A, Bostad L, Svarstad E.

Eur J Hum Genet. 2011 Nov;19(11):1111. doi: 10.1038/ejhg.2011.87. Epub 2011 May 18. No abstract available.

26.

Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.

Najafian B, Svarstad E, Bostad L, Gubler MC, Tøndel C, Whitley C, Mauer M.

Kidney Int. 2011 Mar;79(6):663-670. doi: 10.1038/ki.2010.484. Epub 2010 Dec 15.

27.
28.

The RB (pRb2/p16) and p53 (p14/p53/p21) tumor-suppressor pathways in endemic Burkitt lymphoma.

Kalungi S, Wabinga H, Bostad L.

J Pediatr Hematol Oncol. 2011 Mar;33(2):e54-9. doi: 10.1097/MPH.0b013e3181edf543.

PMID:
21127431
29.

Thrombotic microangiopathy and the antiphospholipid syndrome.

Johnsen SJ, Valborgland T, Gudlaugsson E, Bostad L, Omdal R.

Lupus. 2010 Nov;19(13):1569-72. doi: 10.1177/0961203310375262. Epub 2010 Jul 20.

PMID:
20647251
30.

Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease.

Vikse BE, Hallan S, Bostad L, Leivestad T, Iversen BM.

Nephrol Dial Transplant. 2010 Oct;25(10):3289-96. doi: 10.1093/ndt/gfq169. Epub 2010 Mar 26.

PMID:
20348149
31.
32.

Lymphomas diagnosed in Uganda during the HIV/AIDS pandemic.

Kalungi S, Wabinga H, Molven A, Bostad L.

East Afr Med J. 2009 May;86(5):226-32.

PMID:
20084991
33.

Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN).

Fogo AB, Bostad L, Svarstad E, Cook WJ, Moll S, Barbey F, Geldenhuys L, West M, Ferluga D, Vujkovac B, Howie AJ, Burns A, Reeve R, Waldek S, Noël LH, Grünfeld JP, Valbuena C, Oliveira JP, Müller J, Breunig F, Zhang X, Warnock DG; all members of the International Study Group of Fabry Nephropathy (ISGFN).

Nephrol Dial Transplant. 2010 Jul;25(7):2168-77. doi: 10.1093/ndt/gfp528. Epub 2009 Oct 15.

34.

The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.

Zubac DP, Bostad L, Kihl B, Seidal T, Wentzel-Larsen T, Haukaas SA.

J Urol. 2009 Nov;182(5):2144-9. doi: 10.1016/j.juro.2009.07.015. Epub 2009 Sep 15.

PMID:
19758660
35.

pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda.

Kalungi S, Steine SJ, Wabinga H, Bostad L, Molven A.

BMC Clin Pathol. 2009 Aug 19;9:6. doi: 10.1186/1472-6890-9-6.

36.

Reactive lymphadenopathy in Ugandan patients and its relationship to EBV and HIV infection.

Kalungi S, Wabinga H, Bostad L.

APMIS. 2009 Apr;117(4):302-7. doi: 10.1111/j.1600-0463.2009.02444.x.

PMID:
19338518
37.

Observation should be considered as an alternative in management of renal masses in older and comorbid patients.

Beisland C, Hjelle KM, Reisaeter LA, Bostad L.

Eur Urol. 2009 Jun;55(6):1419-27. doi: 10.1016/j.eururo.2008.12.031. Epub 2009 Jan 7.

PMID:
19147267
38.

Organ-confined clear cell renal cell carcinoma: the prognostic impact of microvascular invasion, nuclear grade and tumour size.

Zubac DP, Bostad L, Kihl B, Eide J, Wentzel-Larsen T, Haukaas SA.

APMIS. 2008 Dec;116(12):1027-33. doi: 10.1111/j.1600-0463.2008.01071.x.

PMID:
19133004
39.

The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomy.

Zubac DP, Bostad L, Seidal T, Wentzel-Larsen T, Haukaas SA.

BMC Urol. 2008 Dec 19;8:19. doi: 10.1186/1471-2490-8-19.

40.

Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria.

Tøndel C, Bostad L, Hirth A, Svarstad E.

Am J Kidney Dis. 2008 May;51(5):767-76. doi: 10.1053/j.ajkd.2007.12.032. Epub 2008 Mar 20. Erratum in: Am J Kidney Dis. 2009 Mar;53(3):567.

PMID:
18436087
41.

Prominence of glomerular and vascular changes in renal biopsies in children and adolescents with Fabry disease and microalbuminuria.

Tøndel C, Bostad L, Laegreid LM, Houge G, Svarstad E.

Clin Ther. 2008;30 Suppl B:S42. No abstract available.

PMID:
18395135
42.

Long-term risk of cancer in membranous nephropathy patients.

Bjørneklett R, Vikse BE, Svarstad E, Aasarød K, Bostad L, Langmark F, Iversen BM.

Am J Kidney Dis. 2007 Sep;50(3):396-403.

PMID:
17720518
43.

Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy.

Zubac DP, Bostad L, Gestblom C, Kihl B, Seidal T, Wentzel-Larsen T, Bakke AM.

Scand J Urol Nephrol. 2007;41(3):191-7.

PMID:
17469026
44.

Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy.

Voltersvik P, Bostad L, Dyrhol-Riise AM, Eide GE, Røsok BI, Olofsson J, Asjö B.

J Acquir Immune Defic Syndr. 2006 Mar;41(3):277-84.

PMID:
16540928
45.

Adverse perinatal outcome and later kidney biopsy in the mother.

Vikse BE, Irgens LM, Bostad L, Iversen BM.

J Am Soc Nephrol. 2006 Mar;17(3):837-45. Epub 2006 Jan 18.

46.

Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabry's disease.

Svarstad E, Bostad L, Kaarbøe O, Houge G, Tøndel C, Lyngdal PT, Iversen BM.

Clin Nephrol. 2005 May;63(5):394-401.

PMID:
15909601
47.

Bedside stereomicroscopy of renal biopsies may lead to a rapid diagnosis of Fabry's disease.

Svarstad E, Iversen BM, Bostad L.

Nephrol Dial Transplant. 2004 Dec;19(12):3202-3. No abstract available.

PMID:
15575014
48.

Co-occurrence of Epstein-Barr virus infection and ascites in sarcoidosis.

Bassøe CF, Hausken T, Bostad L, Kristoffersen EK.

Scand J Infect Dis. 2004;36(3):232-4.

PMID:
15119374
49.

Effects of the endothelin-1 receptor antagonist tezosentan on renal blood flow and diuresis during prolonged increased intra-abdominal pressure.

Gudmundsson FF, Viste A, Myking OL, Grong K, Bostad L, Svanes K.

J Surg Res. 2003 Nov;115(1):33-40.

PMID:
14572770
50.

Supplemental Content

Loading ...
Support Center